- Country: USA
- Summary: Preventative Maintenance Agreement for 36 Heracell Vios 160i CO2 incubators
- UST Ref No: 131700827
- Deadline: 18 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: NOI-CC-26-000054
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Thermo Fisher Scientific Asheville LLC.
Acquisition Description:
The National Institutes of Health, Office of Purchasing and Contracts on behalf of Center for Cellular Engineering (CCE) department intends to award a firm-fixed priced contract to Thermo Fisher Scientific, for a preventative maintenance agreement for the following incubators 36 models equipment: HERA VIOS 160i CO2 with a list of serial numbers.
This acquisition is to purchase a Thermo Scientific instrument service preventative maintenance agreement for the following equipment, 36 models: HERA VIOS 160i CO2. The manufacturing operations of the Center for Cellular Engineering are regulated by the Current Good Manufacturing Practices (cGMPs) as mandated by the FDA in 21 CFR 210, 211, 600 and 1271. The FDA mandates that critical equipment used in the manufacturing, processing, and testing of drug product must be maintained in a controlled manner (21 CFR 211.63, 21 CFR 211.67).
The Department of Transfusion Medicine, Center for Cellular Engineering Services requires a preventative maintenance agreement for 36 Heracell Vios 160i CO2 incubators. The Department of Transfusion Medicine, Center for Cellular Engineering Service manufactures cell-based therapies for patients enrolled on clinical trials. The activities of the Department of Transfusion Medicine, Center for Cellular Engineering Service are regulated by the Food and Drug Administration that mandates critical equipment used in the manufacturing, processing, and testing of drug product be maintained in a controlled manner (21 CFR 211.63, 21 CFR 211.67). Thermo Fisher Scientific has been performing these services and is the original equipment manufacturer capable of performing these services and perform software updates. The Food and... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPreventative Maintenance Agreement for 36 Heracell Vios 160i CO2 incubators - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Preventative Maintenance Agreement for 36 Heracell Vios 160i CO2 incubators. This tender is published on USARFP under UST Ref No: 131700827 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-18.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
